Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
RC11C3, Pilot Placebo-controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Sponsor: Academic and Community Cancer Research United
A PHASE2 clinical study on Pain and Peripheral Neuropathy, this trial is completed. The trial is conducted by Academic and Community Cancer Research United and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
May 2018 — Jun 2018 [monthly]
Completed PHASE2
Phase: NA → PHASE2
▶ Show 3 earlier versions
-
Jul 2017 — May 2018 [monthly]
Completed NA
-
Feb 2017 — Jul 2017 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Academic and Community Cancer Research United
For direct contact, visit the study record on ClinicalTrials.gov .